documents: FDA-2026-P-1792-0005

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-P-1792-0005 FDA FDA-2026-P-1792 Attachment 3 - Draft Package Insert Proposed for Pregabalin Extended-Release Tablets, 247.5 mg, 495 mg and 660 mg Supporting & Related Material Background Material 2026-02-19T05:00:00Z 2026 2     2026-02-19T17:46:25Z   0 0 09000064b91b9245

Links from other tables